Diabetes mellitus (DM) is a strong risk factor for the development of cardiovascular diseases
such as coronary heart disease, cerebrovascular disease, and peripheral arterial disease …

Inflammation is a key feature of atherosclerosis and its clinical manifestations. The leukocyte
count has emerged as a marker of inflammation that is widely available in clinical practice …

Clinical studies reveal changes in blood eosinophil counts and eosinophil cationic proteins
that may serve as risk factors for human coronary heart diseases. Here we report an …

The main adverse reactions to coronary stents are in-stent restenosis (ISR) and stent
thrombosis. Along with procedural factors, individual susceptibility to these events plays an …

Following protein adsorption/activation which is the first step after the contact of material
surfaces and whole blood (part 2), fibrinogen is converted to fibrin and platelets become …

Inflammation is an important player both for the initiation and progression of coronary artery
disease and for coronary plaque instability. Moreover, inflammation contributes to stent …

Aims Blood eosinophil count and eosinophil cationic protein (ECP) concentration are risk
factors of cardiovascular diseases. This study tested whether and how eosinophils and ECP …

Coronary heart disease (CHD) is a type of cardiovascular disease with the highest mortality
rate worldwide. Percutaneous translu-minal coronary intervention (PCI) is the most effective …

AIMS: Coronary atherosclerosis is a chronic inflammatory disease, but different inflammatory
biomarkers may reflect different phases of atherosclerotic plaque evolution. We aimed at …

Type 2 immunity participates in the pathogeneses of helminth infection and allergic
diseases. Emerging evidence indicates that the components of type 2 immunity are also …